Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Sales | 0 | 0 | 0 | 200 | 0 |
| Gross Profit | 0 | 0 | 0 | 200 | 0 |
| Operating Expenses | 1,240 | 1,260 | 1,100 | 1,650 | 1,270 |
| Operating Income | -1,240 | -1,260 | -1,100 | -1,450 | -1,270 |
| Interest Expense | 30 | 40 | 20 | 30 | 30 |
| Other Income | -810 | -150 | 60 | -40 | 270 |
| Pre-tax Income | -2,080 | -1,450 | -1,060 | -1,520 | -1,030 |
| Net Income Continuous | -2,086 | -1,439 | -1,061 | -2,567 | -1,039 |
| Net Income | $-2,086 | $-1,439 | $-1,061 | $-2,567 | $-1,039 |
| EPS Basic Total Ops | -2,400.00 | -1,600.00 | -1,600.00 | -3,200.00 | -1,600.00 |
| EPS Basic Continuous Ops | -1,604.62 | -1,439.00 | -964.55 | -2,567.00 | -1,039.00 |
| EPS Diluted Total Ops | -2,400.00 | -1,600.00 | -1,600.00 | -3,200.00 | -1,600.00 |
| EPS Diluted Continuous Ops | -1,604.62 | -1,439.00 | -964.55 | -2,567.00 | -1,039.00 |
| EBITDA(a) | $-1,430 | $-1,190 | $-920 | $-1,390 | $-1,360 |